Clinical Study of AL2846 Capsules in the Treatment of Advanced Lung Tumor and Advanced Ovarian Cancer
Clinical trial NCT05815862 · COMPLETED
Trial details
- NCT number
- NCT05815862
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-15
- Primary completion
- 2025-08-20
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.